Subclinical hypothyroidism: association with cardiovascular risk factors and components of metabolic syndrome

References

• Canaris GJ, Manowitz NR, Mayor G, Ridgway EC. The Colorado thyroid disease prevalence study. Arch Int Med. 2000;160(4):526–534.
   PubMed Web of Science ®Google Scholar
• Vanderpump MP, Tunbridge WM, French JM, Appleton D, Bates D, Clark F, Grimley Evans J, Hasan DM, Rodgers H, Tunbridge F. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin Endocrinol. 1995;43(1):55–68.
   PubMed Web of Science ®Google Scholar
• Duntas LH. Subclinical hypothyroidism: a misnomer in search of a new name. Thyroid. 2001;11(4):361–362.
   PubMed Web of Science ®Google Scholar
• Kunz R, Vigersky RA, Guyatt GH, Montori VM. A case for clarity, consistency, and helpfulness: state-of-the-art clinical practice guidelines in endocrinology using the grading of recommendations, assessment, development, and evaluation system. J Clin Endocrinol Metabolism. 2008;93(3):666–673.
   PubMed Web of Science ®Google Scholar
• Hollowell JG, Staehling NW, Flanders WD, Hannon WH, Gunter EW, Spencer CA, Braverman LE. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metabolism. 2002;87(2):489–499.
   PubMed Web of Science ®Google Scholar
• Vanderpump MP, Tunbridge WM. Epidemiology and prevention of clinical and subclinical hypothyroidism. Thyroid. 2002;12(10):839–847.
   PubMed Web of Science ®Google Scholar
• Razvi S, Weaver JU, Vanderpump MP, Pearce SHS. The incidence of ischemic heart disease and mortality in people with subclinical hypothyroidism: re-analysis of the Whickham Survey cohort. J Clin Endocrinol Metabolism. 2010;95(4):1734–1740.
   PubMed Web of Science ®Google Scholar
• Ford ES, Giles WH, Dietz WH. Prevalence of metabolic syndrome among US adults: findings from National Health and Nutrition Examination Survey. JAMA. 2002;287 (3):356–359.
   PubMed Web of Science ®Google Scholar
• Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. Executive summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult treatment Panel III). JAMA 2001;285(19):2486–2497.
   PubMed Web of Science ®Google Scholar
• Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC Jr, Spertus JA, Costa F. AHA Scientific statement –diagnosis and management of the metabolic syndrome. Circulation. 2005;112:e285–e290.
   Google Scholar
• Riesen WF. Lipid metabolism. In: Thomas L, editor. Clinical laboratory diagnostics. Use and assessment of clinical laboratory results. Frankfurt/Main: TH-Books Verlagsgesellschaft; 1998. p. 167–169.
   Google Scholar
• Kaplan LA, Pesce AJ, editors. Clinical chemistry theory, analysis and correlation. 3rd ed. St. Louis (MO): C.V. Mosby Co.; 1996. p. 465.
   Google Scholar
• Riesen WF. Lipid metabolism. In: Thomas L, editor. Clinical laboratory diagnostics. Use and assessment of clinical laboratory results. Frankfurt: TH-Books Verlagsgesellschaft; 1998. p. 171–173.
   Google Scholar
• Burtis CA, Ashwood ER, editors. Tietz textbook of clinical chemistry. 3rd ed. Philadelphia (PA): WB Saunders; 1999. p. 849.
   Google Scholar
• Thomas L. Blood glucose. In: Thomas L, editor. Clinical laboratory diagnostics. Use and assessment of clinical laboratory results. Frankfurt: TH-Books Verlagsgesellschaft; 1998. p. 131–137.
   Google Scholar
• Hak AE, Pols HA, Visser TJ, Drexhage HA, Hofman A, Witteman JC. Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study. Ann Intern Med. 2000;132(4):270–278.
   PubMed Web of Science ®Google Scholar
• Imaizumi M, Akahoshi M, Ichimaru S, Nakashima E, Hida A, Soda M, Usa T, Ashizawa K, Yokoyama N, Maeda R, Nagataki S, Eguchi K. Risk for ischemic heart disease and all-cause mortality in subclinical hypothyroidism. J Clin Endocrinol Metabolism. 2004;89(7):3365–3370.
   PubMed Web of Science ®Google Scholar
• Anand P, Sudharani D, Nagaraj DD. Assesment of the cardiovascular risk in subclinical hypothyroidism. Int J Pharm Biol Sci. 2012;2(21):128–134.
   Google Scholar
• Saltiki K, Voidonikola P, Stamatelopoulos K, Mantzou E, Papamichael C, Alevizaki M. Association of thyroid function with arterial pressure in normotensive and hypertensive euthyroid individuals: a cross-sectional study. Thyroid Res. 2008;1(1):1–3.
   PubMedGoogle Scholar
• Althaus BU, Staub JJ, Ryff-De Leche A, Oberhansli A, Stahelin HB. LDL/HDL changes in subclinical hypothyroidism: possible risk factor for coronary disease. Clin Endocrinol. 1988;2(28):157–163.
   Web of Science ®Google Scholar
• Pearce EN. Update in lipid alterations in subclinical hypothyroidism. J Clin Endocrinol Metabolism. 2012;97(2):326–333.
   PubMed Web of Science ®Google Scholar
• Gotto AM. The ILIB lipid handbook for clinical practise: dyslipidemia and coronary heart disease. 2nd ed. New York (NY): International Lipid Information Bureau; 2000.
   Google Scholar
• Danese MD, Ladenson PW, Meinert CL, Powe NR. Clinical review 115: effect of thyroxine therapy on serum lipoproteins in patients with mild thyroid failure: a quantitative review of the literature. J Clin Endocrinol Metabolism. 2000;85(9):2993–3001.
   PubMed Web of Science ®Google Scholar
• Teixeira PF, Reuters VS, Ferreira MM, Almeida CP, Reis FA, Melo BA, Buescu A, Costa AJ, Vaisman M. Treatment of subclinical hypothyroidism reduces atherogenic lipid levels in a placebo-controlled double-blind clinical trial. Horm Metab Res. 2008;40(1):50–55.
   PubMed Web of Science ®Google Scholar
• Köroglu BK, Bagci Ö, Ersoy IH, Aksu O, Balkarli A, Alanoglu E, Tamer MN. Effects of levothyroxine treatment on cardiovascular risk profile and carotida intima media thickness in patients with subclinical hypothyroidism. Acta Endocrinologica (Buc). 2012;8(3):433–442.
   Web of Science ®Google Scholar
• Monzani F, Caraccio N, Kozàkowà M, Dardano A, Vittone F, Virdis A, Taddei S, Palombo C, Ferrannini E. Effect of levothyroxine replacement on lipid profile and intima-media thickness in subclinical hypothyroidism: a double-blind, placebo-controlled study. J Clin Endocrinol Metabolism. 2004;89(5):2099–2106.
   PubMed Web of Science ®Google Scholar
• Rodondi N, Bauer DC. Subclinical hypothyroidism and cardiovascular risk: how to end the controversy. J Clin Endocrinol Metabolism. 2013;98(6):2267–2269.
   PubMed Web of Science ®Google Scholar
• Garduno-Garcia Jde J, Alvirde-Garcia U, Lopez-Carrasco G, Padilla Mendoza ME, Mehta R, Arellano-Campos O, Choza R, Sauque L, Garay-Sevilla ME, Malacara JM, Gomez-Perez FJ, Aguilar-Salinas CA. TSH and free thyroxine concentrations are associated with differing metabolic markers in euthyroid subjects. Eur J Endocrinol. 2010;163(2):273–278.
   PubMed Web of Science ®Google Scholar
• Velija-Asimi Z, Karamehic J. The effects of treatment of subclinical hypothyroidism on metabolic control and hyperinsulinemia. Med Arch. 2007;61(1):20–21.
   Google Scholar
• Maratou E, Hadjidakis DJ, Kollias A. Studies of insulin resistance in patients with clinical and subclinical hypothyroidism. Eur J Endocrinol 2009;160:785–790.
   PubMed Web of Science ®Google Scholar
• Asvold BO, Bjoro T, Vatten LJ. Association of serum TSH with body mass differs between smokers and never smokers. J Clin Endocrinol Metabolism. 2009;94:5023–5027.
   PubMed Web of Science ®Google Scholar
• Erdogan M, Canataroglu A, Ganidagli S, Kulaksizoglu M. Metabolic syndrome prevalence in subclinic and overt hypothyroid patients and relation among metabolic syndrome parameters. J Endocrinol Investig. 2011;34:488–492.
   PubMed Web of Science ®Google Scholar
• Shantha GP, Kumar AA, Jeyachandran V, Rajamanickam D, Rajkumar K, Salim S, Subramanian KK, Natesan S. Association between primary hypothyroidism and metabolic syndrome and the role of the C reactive protein: a cross-sectional study from South India. Thyroid Res. 2009;2:2.
   PubMedGoogle Scholar
• Ogbera AO, Kuku S, Dada O. The metabolic syndrome in the thyroid disease: a report from Nigeria. Indian J Endocrinol Metabolism. 2012;16(3):417–422.
   Google Scholar
• Ruhla S, Weickert MO, Arafat AM, Osterhoff M, Isken F, Spranger J, Schöfl C, Pfeiffer AF, Möhlig M. A high normal TSH is associated with the metabolic syndrome. Clin Endocrinol (Oxford). 2010;72(5):696–701.
   PubMed Web of Science ®Google Scholar
• Kota SK, Meher LK, Krishna S, Modi K. Hypothyroidism in metabolic syndrome. Indian J Endocrinol Metabolism. 2012;16(2):332–333.
   Google Scholar